Ban of Phthalates In Toys Should Be Permanent: CPSC Report

The U.S. Consumer Product Safety Commission (CPSC) is being urged to make a temporary ban that keeps a class of chemicals known as phthalates out of toys permanent, due to the potential risks exposure to the plasticizers carries for children.

In a report (PDF) issued July 18, the agency’s Chronic Hazard Advisory Panel (CHAP) concluded that phthalate exposure can lead to reduced anogenital distance (AGD) in boys and other sexual developmental problems. As a result, the panel recommends that many iterations of theย chemicalย should be permanently banned from children’s toys.

“Overall, the epidemiological literature suggests that phthalate exposure during gestation may contribute to reduced AGD and neurobehavioral effects in male infants or children,” the report states. “Other limited studies suggest that adult phthalate exposure may be associated with poor sperm quality.”

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

There are 14 different phthalates that were part of the review, as well as six alternative chemicals. Several have already been permanently banned, some were temporarily banned and others are not banned at all.

The CHAP recommends that the CPSC make those phthalates that have been temporarily banned become banned permanently, and that it continue to permanently ban those already permanently banned. However, the CHAP report noted that toys were a minor source of phthalate exposure. Most phthalate exposure comes from food, beverages and drugs, according to the report.

Phthalates are a class of industrial compounds commonly known as plasticizers. The chemicals are often used to make plastic more flexible or to help cosmetics slide on more smoothly.

In addition to toys, phthalates are found in food packaging, detergents, textiles, plastic tubing used in hospitals to deliver medications, the coatings on pills, including some aspirin, and many other products. They are known endocrine disruptors, which interfere with the natural way the body regulates and produces hormones. Studies have found phthalates may contribute to a slew of side effects, including birth defects, cancer, diabetes and infertility.

Research published in 2011 found phthalates interfere with the proper functioning of the thyroid and can result in a decrease in thyroid hormones by 10 percent following high exposure to the chemical.

A study published in Februaryย revealed that phthalates, commonly used to seal and contain food products, may leach into the food they package causing severe side effects. Because they are used in so many consumer products, any harmful effects could be widespread.

A study published in March, in the medical journal also found that phthalates could have negative effects on male fertility.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

In a joint statement, plaintiffs and defendants in AngioDynamics port catheter lawsuits have laid guidelines for what types of cases should be selected to serve as potential bellwether trials.
Women who experienced infection, chronic inflammation, implant instability or other complications after internal bra mesh procedures are now questioning whether those risks were fully disclosed before implantation.
More than 3,300 women have filed Depo-Provera lawsuits in federal court, with several hundred more also pending in state courts in New York and Delaware, according to a recent status report.